Search
for
Sort by
Research 181–210 of 1000+
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- New hopes and strategies for the treatment of severe ocular surface disease
- Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know
- JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
- 708 Promotion of hair growth in alopecia areata by topical treatment of HDAC inhibitors
- Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
- Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment through Antioxidant Pathways that Differ from Minoxidil
- Androgenetic Alopecia in Adolescents
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Managing patterned hair loss – a hair raising task!
- Evaluation of the effectiveness of fractional lasers in the treatment of androgenetic alopecia: a literature review
- Targeting PrfA from Listeria monocytogenes: a computational drug repurposing approach
- Editorial Note on Next-Generation Therapies and Advance Acne Treatment
- Faculty Opinions recommendation of Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature.
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Biological therapy in the treatment of melanoma
- Androgenic alopecia updates
- Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model
- Polycystic Ovary Syndrome
- Androgenetic alopecia – Current status
- The inflammatory component of androgenetic alopecia
- Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years
- CURRENT PROSPECTIVE IN THE MANAGEMENT OF DEPRESSION USING OFF LABELLED DRUGS AND ADVANCED DRUGS
- Deuruxolitinib for Alopecia Areata.
- Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations